Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice

Journal of Clinical Investigation

Volumn 100, Issue 11, 1997, Pages 2744-2751

  Wennbo, Håkan ^a   Gebre Medhin, Maria ^a   Gritli Linde, Amel ^a   Ohlsson, Claes ^b   Isaksson, Olle G P ^b   Törnell, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Auto paracrine; Growth hormone; Mammary neoplasm; Prolactin; Transgenic mice

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; PROLACTIN; PROLACTIN RECEPTOR; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; CONTROLLED STUDY; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0031454715     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119820     Document Type: Article

References (43)

1. Ben-Jonathan, N., J.L. Mershon, D.L. Allen, and R.W. Steinmetz. 1996. Extrapituitary prolactin: distribution, regulation, functions and clinical aspects. Endocr. Rev. 17:639-669.
2. Neville, M.C., and C.W. Daniel. 1987. The Mammary Gland. Development, Regulation and Function. Plenum Publishing Corporation, New York.
3. Ormandy, C.J., A. Camus, J. Barra, D. Damotte, B. Lucas, H. Buteau, M. Edery, N. Brousse, C. Babinet, et al. 1997. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11: 167-178.
4. Bonneterre, J., J.P. Peyrat, R. Beuscart, J. Lefebvre, and A. Demaille. 1987. Prognostic significance of prolactin receptors in human breast cancer. Cancer Res. 47:4724-4728.
5. Murphy, J.L., L.C. Murphy, E. Vrhovesek, R.L. Sutherland, and L. Lazarus. 1984. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Cancer Res. 44:1963-1968.
6. Biswas, R., and B.K. Vonderhaar. 1987. Role of serum in the prolactin responsivness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Res. 47:3509-3514.
7. Manni, A., C. Wright, G. Davis, J. Glenn, R. Joehl, and P. Feil. 1986. Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay. Cancer Res. 46:1669-1672.
8. Shiu, R.P. 1979. Prolactin receptors in human breast cancer cells in long-term tissue culture. Cancer Res. 39:4381-4386.
9. Fuh, G., and J.A. Wells. 1995. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J. Biol. Chem. 270:13133-13137.
10. Matsuzawa, A. 1986. Hormone dependence and independence of mammary tumors in mice. In International Review of Cytology. G.H. Bourne and K.W. Jeon, editors. Academic Press, New York. 103:303-341.
11. Goffin, V., K.T. Shiverick, P.A. Kelly, and J.A. Martial. 1996. Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr. Rev. 17: 385-410.
12. Bazan, J.P. 1989. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erytropoietin and IL-6 receptors, and the p75 IL-2 receptor B chain. Biochem. Biophys. Res. Commun. 164:788-795.
13. Alexander, L., D. Appleton, R. Hall, W.M. Ross, and R. Wilkinsson. 1980. Epidemiology of acromegaly in the Newcastle region. Clin. Endocrinol. 12:71-79.
14. Bengtsson, B.Å., S. Edén, I. Ernest, A. Odén, and B. Sjögren. 1988. Epidemiology and long-term survival in acromegaly. Acta. Med. Scand. 223:327-335.
15. Nabarro, J.D. Acromegaly. 1987. Clin. Endocrinol. 26:327-335.
16. Ituarte, E.M., J. Pertini, and M. Hershman. 1984. Acromegaly and colon cancer. Ann. Intern. Med. 101:627-628.
17. Decouvelaere, C., J.P. Peyrat, J. Bonneterre, J. Dijane, and H. Jammes. 1995. Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancer. Cell Growth Differ. 6:477-483.
18. Törnell, J., L. Rymo, and O.G.P. Isaksson. 1991. Induction of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice. Int. J. Cancer. 49:114-117.
19. Bartke, A., M. Cecim, K. Tang, R.W. Steger, V. Chandrashekar, and D. Turyn. 1994. Neuroendocrine and reproductive consequences of overexpression of growth hormone in transgenic mice. Proc. Soc. Exp. Biol. Med. 206:345-359.
20. Törnell, J., B. Carlsson, P. Pohjanen, H. Wennbo, L. Rymo, and O.G.P. Isaksson. 1992. High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice. J. Steroid. Biochem. Mol. Biol. 43:237-242.
21. D'Ercole, A.J., A.D. Stiles, and L.E. Underwood. 1984. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. USA. 81: 935-939.
22. Mathews, L.S., G. Norstedt, and R.D. Palmiter. 1986. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc. Natl. Acad. Sci. USA. 83:9343-9347.
23. Yee, D., S. Paik, G.S. Lebovic, R.R. Marcus, R.E. Favoni, K. Cullen, M.E. Lippman, and N. Rosen. 1989. Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol. Endocrinol. 3:509-517.
24. Cullen, K.J., D. Yee, W.S. Sly, J. Perdue, B. Hampton, M.E. Lippman, and N. Rosen. 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res. 50:48-53.
25. Huff, K.K., D. Kaufman, K.H. Gabbay, E.M. Spencer, M.E. Lippman, and R.B. Dickson. 1986. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res. 46:4613-4619.
26. Karey, K.P., and D.A. Sirbasku. 1988. Differential responsivness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17b-estradiol. Cancer Res. 48:4083-4092.
27. Mathews, L.S., R.E. Hammer, R.R. Behringer, A.J. D'Ercole, G.I. Bell, R.L. Brinster, and R.D. Palmiter. 1988. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology. 123:2827-2833.
28. Neuenschwander, S., A. Schwartz, T.L. Wood, C.T.J. Roberts, L. Hennighausen, and D. LeRoith. 1996. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J. Clin. Invest. 97: 2225-2232.
29. Hadsell, D.L., N.M. Greenberg, J.M. Fligger, C.R. Baumrucker, and J.M. Rosen. 1996. Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology. 137:321-330.
30. Bates, P., R. Fisher, A. Ward, L. Richardson, D.J. Hill, and C.F. Graham. 1995. Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br. J. Cancer. 72:1189-1193.
31. Mathews, L.S., R.E. Hammer, R.L. Brinster, and R.D. Palmiter. 1988. Expression of insulin-like growth factor 1 in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology. 123:433-437.
32. Cooke, N.E., and J.D. Baxter. 1982. Structural analysis of the prolactin gene suggests a separate origin for its 5-end. Nature. 297:603-606.
33. Palmiter, R.D., R.L. Brinster, R.E. Hammer, M.E. Trumbauer, M.G. Rosenfeld, N.C. Brinberg, and M.E. Trumbauer. 1982. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature. 300:611-615.
34. Hogan, B., F. Costantini, and E. Lacy. 1986. Manipulating the Mouse Embryo. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
35. Öferstedt, L.G., K. Hammarström, N. Balgobin, S. Hjertén, U. Pettersson, and J. Chattopadhyaya. 1984. Rapid and quantitative recovery of DNA fragments from gels by displacement electrophoresis (isotachophoresis). Biochim. Biophys. Acta. 782:120-126.
36. Hammer, R.E., R.L. Brinster, and R.D. Palmiter. 1985. Use of gene transfer to increase animal growth. Cold Spring Harbor Symp. Quant. Biol. 50: 179-387.
37. Chomcynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid Quanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
38. Cooke, N.E., D. Coit, R.I. Weiner, J.D. Baxter, and J.A. Martial. 1980. Structure of cloned DNA complementary to rat prolactin messenger RNA. J. Biol. Chem. 255:6502-6510.
39. Sandstedt, J., C. Ohlsson, E. Norjavaara, J. Nilsson, and J. Törnell. 1994. Disproportional bone growth and reduced weight gain in gonadectomize male bovine growth hormone transgenic and normal mice. Endocrinology. 135:2574-2580.
40. Sinha, Y.N., C.B. Salocks, M.A. Wickes, and W.P. Vanderlaan. 1977. Serum and pituitary concentrations of prolactin and growth hormone in mice during a twenty-four hour period. Endocrinology. 100:786-791.
41. Huseby, R.A., M.J. Soares, and F. Talamantes. 1985. Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas. Endocrinology. 116: 1440-1448.
42. Adler, R.A. 1986. The anterior pituitary-grafted rat: a valid model of chronic hyperprolactinemia. Endocr. Rev. 7:302-313.
43. Ginsburg, E., and B.K. Vonderhaar. 1995. Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 55:2591-2595.